Torben Moos

Torben Moos

Professor

Department of Health Science and Technology

Neurobiology Research and Drug Delivery

Aalborg University, Denmark

About the Speaker:

The fields of study he is best known for:

Biochemistry

Internal medicine

Cancer

Torben Moos mainly investigates Transferrin, Transferrin receptor, Blood–brain barrier, Immunology and Cell biology. His research integrates issues of Transcytosis, Receptor, Endocytosis and Choroid plexus in his study of Transferrin. Torben Moos combines subjects such as Endothelial stem cell and Cerebrospinal fluid with his study of Transferrin receptor.

Central nervous system covers Torben Moos research in Blood–brain barrier. The various areas that he examines in his Immunology study include Liposome and Drug delivery. His research in Cell biology intersects with topics in Laminin, Astrocyte, Dementia, Ferritin and Iron deficiency.

His most cited work include:

A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy

Proteasomal Inhibition by α-Synuclein Filaments and Oligomers

Iron trafficking inside the brain

His primary areas of investigation include Blood–brain barrier, Cell biology, Transferrin receptor, Transferrin and Internal medicine. He interconnects Molecular biology and In vitro, Biochemistry in the investigation of issues within Blood–brain barrier. His research integrates issues of Endocytosis, Capillary endothelial cells, Neuroscience and Ferroportin in his study of Cell biology.

His research in Transferrin receptor intersects with topics in Transcytosis, Immunology, Parenchyma and Iron deficiency. His Transferrin research integrates issues from Endothelium, DMT1, Ferritin and Choroid plexus. As part of one scientific family, Torben Moos deals mainly with the area of Choroid plexus, narrowing it down to issues related to the Pathology, and often Microglia.

Selected Recent Publications:

1. Thomsen MS, Kostrikov S, Routhe LG, Johnsen KB, Helgudóttir SS, Gudbergsson JM, Andresen TL, Moos T (2025) Remodeling of the brain angioarchitecture in experimental chronic neurodegeneration. Neurobiol Dis. 204:106761.

2. Thomsen MS, Johnsen KB, Kucharz K, Lauritzen M, Moos T (2022) Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles. Pharmaceutics. 14:2237.